Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG Supplementation in Multiple System Atrophy
NCT02008721Phase 3Completed
- Start
- Jan 2014
- Primary completion
- Sep 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epigallocatechin gallate in multiple system atrophy (MSA). Started Jan 2014; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT02008721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008721.